J.M. Arbour’s AbbVie ABBV Stock Holding History

J.M. Arbour’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$257K	Buy	1,183 +51	+5%	+$11.3K	0.25%	100
2025 Q4	$259K	Buy	+1,132	New	+$258K	0.26%	94

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

J.M. Arbour's ABBV Position: Q1 2026 in Review

J.M. Arbour increased its AbbVie (ABBV) stake by 4.5% in Q1 2026, buying an estimated $11.3K and bringing the position to 1,183 shares worth $257K. The position accounts for 0.25% of the portfolio, ranked #100.

J.M. Arbour first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. The position peaked at $259K in Q4 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

J.M. Arbour held 1,183 shares of AbbVie worth $257K as of Q1 2026.
J.M. Arbour bought 51 AbbVie shares in Q1 2026, an estimated $11.3K.
AbbVie made up 0.25% of J.M. Arbour's portfolio in Q1 2026, its #100 holding.
J.M. Arbour first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
J.M. Arbour's AbbVie position peaked at $259K in Q4 2025.
4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on J.M. Arbour's 13F filing for Q1 2026, filed 21 Apr 2026.